Treatment of factor VIII concentrate to minimize the affect of u

Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3516

Patent

active

045565589

ABSTRACT:
The invention is directed to treating blood clotting Factor VIII products to minimize the presence of undesirable microorganisms involving process steps of drying and heating of the product. In addition the invention is directed to products obtained by the process.

REFERENCES:
patent: 3041242 (1962-06-01), Barr et al.
patent: 3100737 (1963-08-01), Auerswald et al.
patent: 3859168 (1975-01-01), Barth et al.
patent: 4250139 (1981-02-01), Luck et al.
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4327086 (1982-04-01), Fukishima et al.
patent: 4347259 (1982-08-01), Suzuki et al.
patent: 4495278 (1985-01-01), Thomas
Kaplan, "The Heat Inactivation of Vaccinia Virus," J. Gen. Microbiol., 18:58-63, (1958).
Cowdery et al., "Stability Characteristics of Freeze-Dried Human Live Virus Vaccines," Develop. Biol. Standard, 36:297-303.
Beardmore et al., "Preservation of Influenza Virus Infectivity by Lyophilization," Applied Microbiology, 16(2):362-365, (1968).
Greiff et al., "Stability of Suspensions of Influenza Virus Dried to Different Contents of Residual Moisture by Sublimation in Vacuo," Applied Microbiology, 16(6):835-840, (1968).
Plowright et al., "Studies on Rinderpest Culture Vaccine. III. Stability of the Lyophilized Product," Res. Vet. Sci., 11:71-81, (1970).
Apostolov et al., "Selective Inactivation of the Infectivity of Freeze-Dried Sendai Virus by Heat," Cytobiology, 10:255-259, (1973).
Schable et al., "Stability of a Reference Panel of Lyophilized Hepatitis B Antigens and Antibodies," J. Biol. Standardization, 7:293-299, (1979).
Berge et al., "Preservation of Enteroviruses by Freeze-Drying," Applied Microbiology, 22(5):850-853, (1971).
Grieff et al., "An Accelerated Storage Test for Predicting the Stability of Suspensions of Measles Virus Dried by Sublimation in Vacuo," J. Immunology, 94(3):395-400, (1965).
Kraft et al., "Lyophilization of Poliomyelitis Virus. Heat Inactivation of Dry MEFL Virus," Proc. Soc. Exp. Biol. Med., 9:306-309, (1954).
Scatchart et al., "Chemical, Clinical, and Immunological Studies on the Products of Human Plasma Fractionation. IV. A Study of the Thermal Stability of Human Serum Albumin," J. Clin. Invest., 23:445-453, (1944).
Sirridge, Laboratory Evaluation of Hemostatis, Second Edition, Lea & Febiger, Philadelphia, 1974, pp. 7-8.
Bangham et al., "Stability of Some Clotting Factors in Freeze-Dried Factor VIII-Reference Plasma and Concentrate," Chem. Abstracts, 76:22760u, (1972).
Brozovic et al., "Stability of Prothrombin and Factor VII in Freeze-Dried Plasma," J. Clin. Path., 24:690-693, (1971).
Plasma Products: Use and Management. A Technical Workshop, Kolins et al. (Eds.), The Committee on Technical Workshops, American Association of Blood Banks, Anaheim, CA, (1982).
Gerety et al., "Plasma Derivatives and Viral Hepatitis," Transfusion, 22(5):347, (1982).
Tabor et al., Infectious Complications of Blood Transfusion, Academic Press, New York, 1982, pp. 6, 24.
Aronson et al., "Historical and Future Therapeutic Plasma Derivatives (Epilogue)," Seminars in Thombosis and Hemostasis, VI(2):121-123, (1980).
Rosenberg et al., "Thermoinactivation of Virus of Botkin's Disease (Hepatite Virus) in Dry Fibrinogen and Albumin Preparations," XII International Congress on Blood Transfusion Abstracts, MIR Publishers, Moscow, 1969, pp. 473-475.
Soulier et al., "Prevention of Virus B Hepatitis (SH Hepatitis)," Amer. J. Dis. Child, 123:429-434, (1972).
Paine et al., "Human Albumin Infusions and Homologous Serum Jaundice," JAMA, 150(3):199-202, (1952).
Havens et al., "Properties of the Etiologic Agent of Infectious Hepatitis," Proc. Soc. Exp. Biol. Med., 58:203-204, (1945).
Bertrand et al., "Clinical Investigations with a Heat-Treated Plasma Protein Fraction--Plasmanate," Vox Sang., 4385-402, (1959).
Roberts et al., "Post-Transfusion Hepatitis Following the Use of Prothrombin Complex Concentrates," Thrombos, Diathes, Haemorrh., (Stuttg.), 33:610-616, (1975).
Tabor et al., "Removal of Hepatitis-B-Virus Infectivity from Factor-IX Complex by Hepatitis-B Immune-Globulin," The Lancet, pp. 68-70, Jul. 12, 1980.
Allen et al., "Homologous Serum Jaundice and its Relation of Methods of Plasma Storage," JAMA, 144(13):1069-1074, Nov. 25, 1950.
Funakoshi et al., "Injectable Inactivated Vaccine Against Hepatitis B," Chem. Abstracts, 89:65254t, (1978).
Schwinn et al., "Blood Coagulation Factors," Chem. Abstracts, 94:36335t, (1981).
Thomas, Baxter-Travenol, pp. 1-6, 10/29/79.
Bidwell, The Purification of Bovine, Antihemophilic Globulin, Br. J. Hematol., 1:35-45, (1955).
Podolsky et al, Improved Method of Lyophilic Dessication of Glucose Stabilized Plasma, Problems of Hemotology and Blood Transfusion, (1967).
Spaet et al, Prophies of Bovine Anti Hemophilic Factor, Bovine Anti Hemophilic Factor, (1953).
MacFarlane et al, The Use of Animal Antiheomophlin Globulin and Human Plasma in Thirteen Cases, Lancet, (1957).
Thelin et al, Sedimentation of Plasma AntiHemophilic Factor, Archives of Biochemistry and Biophesis, 95, 70-76, (1961).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of factor VIII concentrate to minimize the affect of u does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of factor VIII concentrate to minimize the affect of u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of factor VIII concentrate to minimize the affect of u will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1394041

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.